Sulfasalazine monotherapy is recommended for patients with all disease durations and without poor prognostic features and includes those with all degrees of disease activity.

• 柳氮磺吡啶单一疗法为那些长期患有各种疾病和没有不良预后特征的，包含那些不同严重程度患病的患者推荐。